CORAL SPRINGS, Fla., Oct. 27, 2015 /PRNewswire-iReach/ — The producers of the Health Briefs television show are pleased to announce that PSI CRO will be featured in an upcoming segment on topics, trends, and issues related to “Improving Drug Discovery and Development through Key Technology Solutions”. Developing new drugs for patients takes years of research and billions of dollars. Even then, only 1 out of every 10 ever makes it to the market. Unfortunately, the clinical research phase—the longest and costliest phase—often runs behind schedule, costing millions of dollars in delays. Clinical trials that fall behind schedule not only increase costs, but also delay the access patients have to new medicines.
PSI CRO is a contract research organization otherwise known as a CRO—an organization that performs clinical trials for the pharmaceutical, biotechnology and medical industries. CROs offers drug sponsors the expertise of taking a new drug all the way from conception to FDA and EMA approval, without having to maintain a staff of their own. For its contributions to the industry, PSI CRO has received top honors among global CROs in the biannual CenterWatch Global Investigator Site Survey Report.
Health Briefs TV combs the nation and the globe to bring viewers fascinating business stories and firsthand insights from entrepreneurs within various industries. The television show is broadcast nationally and regionally on many popular television networks.
The Health Briefs TV show is hosted by Kevin Harrington. It is headquartered in South Florida and films on location throughout the United States and Canada. It is broadcast on most regional and national cable television networks. The show is a proud leader of quality, educational programming. It is produced in part by Anthony DiMeglio, Melissa Leibowitz, and Rob Marshall. Join the fans and the show’s staff on popular social sites to discuss and comment on stories of the day. Learn more about Health Briefs TVon Facebook, Google+, Pinterest and health-briefs.com.For more information on PSI CRO, please visit www.psi-cro.com.
Originally distributed by PRNewswire.com